Avisa Myko Inc

Avisa Myko Inc is a biotechnology and manufacturing startup based in the United States, founded in 2019. The company has developed a unique and cost-effective fermentation technology to produce Natural Melanin, which is 4000 times cheaper than the current market cost. Avisa Myko aims to disrupt the industry by offering a cost-efficient solution with various applications in cosmetics, pharma, and industrial settings, including rechargeable magnesium ion and sodium ion batteries. The company has no direct competitors for its Black Eumelanin technology, positioning itself as a pioneering player in the market. Avisa Myko has received seed funding from prominent investors including SOSV, Indiebio Accelerator, Advisors Fund, and VII Ventures. The latest investment was a Seed Round investment on 09 August 2023 led by SOSV and Indiebio. With its focus on eco-friendly solutions, Avisa Myko addresses the environmental concerns associated with sunscreen use. By utilizing melanin as a UV blocker, the company seeks to replace damaging chemicals and nano minerals in sunscreen formulations, offering a biodegradable, non-toxic, and reef-safe alternative. This approach aligns with the growing demand for sustainable products in the $12 billion sunscreen industry. In addition to sunscreen applications, Avisa Myko is exploring other potential uses for melanin, catering to various industries. The innovative technology and the potential to address critical environmental and cost-related challenges make Avisa Myko an intriguing prospect for investors looking to capitalize on disruptive solutions in biotechnology and manufacturing.